# Dapsone

NDC: 21922-018
Generic name: Dapsone Gel, 5%
Labeler / Manufacturer: Encube Ethicals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20231016

FDA application: ANDA212383

## Active ingredients

- DAPSONE: 50 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"21922-018"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=21922-018
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4205a1a9-c459-47bb-9538-1dd559ca71f1